Pharmaceutical Care for COPD Study
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Chronic Obstructive Pulmonary Disease (COPD)
- Sponsor
- University Hospital, Ghent
- Enrollment
- 734
- Locations
- 2
- Primary Endpoint
- inhalation technique baseline
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
This study would like to test the hypothesis that a pharmaceutical care intervention would result in an improved drug adherence and inhalation technique in Chronic Obstructive Pulmonary Disease (COPD) patients over a 3 month-period.
Detailed Description
Effective pharmacologic management of Chronic Obstructive Pulmonary Disease (COPD) not only involves prescription of recommended medicines by the physician, but also implies correct use of the prescribed medication by the patient (ie, good drug adherence and correct inhalation technique). Community pharmacists could help to improve the latter aspect, by delivering pharmaceutical care. The present randomised controlled trial will study the hypothesis that a pharmaceutical care intervention would result in an improved drug adherence and inhalation technique in COPD patients over a 3 month-period.
Investigators
Eligibility Criteria
Inclusion Criteria
- •daily use of Chronic Obstructive Pulmonary Disease (COPD)-medication: (Global initiative for chronic Obstructive Lung Disease: GOLD stadia I-IV)
- •50 years of age or older
- •smoking history of at least 10 pack-years
Exclusion Criteria
- •having asthma
- •analphabetism
Outcomes
Primary Outcomes
inhalation technique baseline
Time Frame: baseline
Inhalation technique with Chronic Obstructive Pulmonary Disease (COPD) controller medication at baseline.
inhalation technique 3 months
Time Frame: after 3 months
Inhalation technique with Chronic Obstructive Pulmonary Disease (COPD) controller medication after 3 months.
drug adherence
Time Frame: after 3 months
Adherence to Chronic Obstructive Pulmonary Disease (COPD) controller medication after 3 months.
inhalation technique 1 month
Time Frame: after 1 month
Inhalation technique with Chronic Obstructive Pulmonary Disease (COPD) controller medication after 1 month.
Secondary Outcomes
- exacerbations(after 3 months)
- Emergency Room visits and hospitalizations.(after 3 months)
- health status(after 3 months)